Evidence map›Paper›PMID 24883262›Full record

ArticleCurrent tropical medicine reports2014

Immunopathogenesis Versus Protection in Dengue Virus Infections.

Alan L Rothman, Carey L Medin, Heather Friberg, Jeffrey R Currier

Abstract read
In one paragraph

Article in Current tropical medicine reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. A review of Dengvaxia®: development to deployment.Human vaccines & immunotherapeutics · 2019
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alan L RothmanInstitute for Immunology and Informatics, College of the Environment and Life Sciences, University of Rhode Island, 80 Washington Street, Providence, RI 02903; Phone +1-401-277-5419; FAX +1-401-277-5244.
Carey L MedinInstitute for Immunology and Informatics, College of the Environment and Life Sciences, University of Rhode Island, 80 Washington Street, Providence, RI 02903; Phone +1-401-277-5419; FAX +1-401-277-5244.
Heather FribergViral Diseases Branch, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD; Phone +1-301-319-9224; FAX +1-301-319-9661.
Jeffrey R CurrierViral Diseases Branch, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD; Phone +1-301-319-3038; FAX +1-301-319-9661.

Funding

VIRAL DETERMINANTS OF SEVERE DENGUE DISEASEP01AI034533 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROTHMAN, ALAN L · 1994 to 2022
$42.0M
NIAID NIH HHS P01 AI034533
6 · The paper itself

Abstract

Dengue viruses (DENV) are mosquito-borne viruses that cause significant morbidity. The existence of four serotypes of DENV with partial immunologic cross-reactivity creates the opportunity for individuals to experience multiple acute DENV infections over the course of their lifetimes. Research over the past several years has revealed complex interactions between DENV and the human innate and adaptive immune systems that can have either beneficial or detrimental influences on the outcome of infection. Further studies that seek to distinguish protective from pathological immune responses in the context of natural DENV infection as well as clinical trials of candidate DENV vaccines have an important place in efforts to control the global impact of this re-emerging viral disease.

Indexed as

denguedengue virus (DENV)DENV vaccineimmunopathogenesisinnate immunityT lymphocytevaccineviral diseaseviral tropical medicine

Identifiers

PMID24883262
PMCPMC4036645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.